Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q4 EPS of ($0.52), $0.01 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $844 thousand versus the consensus estimate of $870 thousand.

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.